Literature DB >> 9823542

Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease.

S Pinamonti1, M Leis, A Barbieri, D Leoni, M Muzzoli, S Sostero, M C Chicca, A Carrieri, F Ravenna, L M Fabbri, A Ciaccia.   

Abstract

Xanthine oxidase (xanthine: oxygen oxidoreductase, EC 1.1.3.22), a molybdenum-containing hydroxylase that produces superoxide and uric acid from purine substrates and molecular oxygen, is involved in the oxidative stress underlying several human pathologies including lung diseases. An enzymatic activity similar to xanthine oxidase was previously reported in bronchoalveolar lavage fluid of patients with chronic obstructive pulmonary disease (COPD-BAL), by fluorometric analysis of DNA unwinding and cytochrome c reduction kinetics. Here we report the detection of xanthine oxidase activity products by electron paramagnetic resonance (EPR) in presence of the spin-trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) and reversed-phase high-performance liquid chromatography (RP-HPLC) in COPD-BAL (n = 14, average age of patients 65 years, range 38-81) and BAL from healthy nonsmoker controls (n = 6, average age 64 years, range 44-73). Superoxide DMPO adducts were detected in COPD-BAL and in an in vitro system containing xanthine and xanthine oxidase (XA/XO), but not in BAL controls and when superoxide dismutase (SOD, 1000 I.U./ml) was added to COPD-BAL. The HPLC analyses after addition of xanthine showed production of uric acid in COPD-BAL and in the XA/XO system but not in BAL controls. These results support the involvement of xanthine oxidase in the mechanisms of superoxide production by BAL supernatant, which increases oxidative stress in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9823542     DOI: 10.1016/s0891-5849(98)00128-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  14 in total

1.  Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process.

Authors:  Stephan F van Eeden; Don D Sin
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

2.  Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.

Authors:  Jonathan Fallica; Lidenys Varela; Laura Johnston; Bo Kim; Leonid Serebreni; Lan Wang; Mahendra Damarla; Todd M Kolb; Paul M Hassoun; Rachel Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 3.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

Review 4.  Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.

Authors:  Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2012-11-06       Impact factor: 8.401

5.  Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue.

Authors:  Matthew J Rossman; H Jonathan Groot; Van Reese; Jia Zhao; Markus Amann; Russell S Richardson
Journal:  Med Sci Sports Exerc       Date:  2013-07       Impact factor: 5.411

Review 6.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

7.  Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide.

Authors:  Irina Petrache; Terry R Medler; Amy T Richter; Krzysztof Kamocki; Ugonma Chukwueke; Lijie Zhen; Yuan Gu; Jeremy Adamowicz; Kelly S Schweitzer; Walter C Hubbard; Evgeny V Berdyshev; Giuseppe Lungarella; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-25       Impact factor: 5.464

Review 8.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

9.  Cyclin-dependent kinase five mediates activation of lung xanthine oxidoreductase in response to hypoxia.

Authors:  Bo S Kim; Leonid Serebreni; Jonathan Fallica; Omar Hamdan; Lan Wang; Laura Johnston; Todd Kolb; Mahendra Damarla; Rachel Damico; Paul M Hassoun
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 10.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.